Abstract
In anticipation that plasma cholesterol levels may be lowered by inhibiting sterol synthesis in the liver, the major organ that supplies plasma cholesterol, studies aimed at identifying the specific inhibitors of cholesterol synthesis of microbial origin were started in my laboratory in 1971. Since then two novel compounds, ML-236B (compactin) and monacolin K, have been discovered and isolated as low-toxic, potent inhibitors of sterol synthesis from 14C acetate in a cell-free enzyme system of rat liver. This paper briefly reviews biological and biochemical data on these two compounds.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brown MS, Faust JR, Goldstein JL, Kaneko I, End A (1978) Induction of 3-hy-droxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J Biol Chem 253: 1121–1128
Doi O, End A (1978) Specific inhibition of desmosterol synthesis by ML-236B in mouse LM cells grown in suspension in a lipid-free medium. Japanese J Med Sci Biol 31: 225–233
End A (1979a) Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiotics 32: 852–854
End A (1979b) Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. FEBS Letters, in press
Endo A, Kuroda M, Tsujit Y (1976a) ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J Antibiotics 29: 1346–1348
Endo A, Kuroda M, Tanzaw K (1976b) Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B, fungal metabolites having hypocholesterolemic activity. FEBS Letters 72: 323–326
Endo A, Tsujita Y, Kuroda M, Tanzaw K (1977) Inhibition of in vitro and in vivo cholesterol synthesis by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Eur J Biochem 77: 31–36
Endo A, Tsujita Y, Kuroda M, Tanzaw K (1979) Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim Biophys Acta, in press
Kaneko I, Hazama-Shimada Y, End A (1978) Effects of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on the lipid metabolism in cultured cells. Eur J Biochem 87: 313–321
Kuroda M, Tanzawa K, Tsujita Y, End A (1977) Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in Triton WR-1339-induced hyperlipidemia. Biochim Biophys Acta 489: 119–125
Kuroda M, Tsujita Y, Tanzawa K, End A (1979) Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Lipids 14: 585–589
Tanzawa K, End A (1979) Kinetic analysis of the reaction catalyzed by 3-hydroxy-3-methylglutaryl coenzyme A reductase using two specific inhibitors. Eur J Biochem 98: 195–201
Tsujita Y, Kuroda M, Tanzawa K, Kitano N, End A (1979) Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase. Atherosclerosis 32: 307–313
Yamamoto A, Sudo H, End A (1979) Therapeutic effects of ML-236B in primary hypercholesterolemia. Atherosclerosis, in press
Editor information
Rights and permissions
Copyright information
© 1980 Springer-Verlag New York Inc.
About this paper
Cite this paper
Endo, A. (1980). Biological and Biochemical Aspects of ML-236B (Compactin) and Monacolin K, Specific Competitive Inhibitors of 3-hydroxy-3-methylglutaryl Coenzyme A Reductase. In: Gotto, A.M., Smith, L.C., Allen, B. (eds) Atherosclerosis V. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6071-4_32
Download citation
DOI: https://doi.org/10.1007/978-1-4612-6071-4_32
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6073-8
Online ISBN: 978-1-4612-6071-4
eBook Packages: Springer Book Archive